Dudediligence.

Immix Biopharma, Inc

IMMXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$7.1MSep ’24−$4.8MDec ’24−$4.5MMar ’25−$6.6MJun ’25−$7.6MSep ’25−$10.6MDec ’25−$10.1MMar ’26−$11.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$1.4M−$8.2M−$16.1M−$22.7M−$30.0M
Net income−$24.4M−$8.2M−$15.4M−$21.6M−$29.4M
Operating cash flow−$1.6M−$7.4M−$11.4M−$14.6M−$23.9M
Free cash flow−$1.6Mnone on file−$11.4M−$15.8M−$24.7M
Cash$17.6M$13.4M$17.5M$17.7M$93.9M
Shares outstanding13.2M13.9M19.9M27.5M53.0M